[18F]MNI-958

DRUG3 trials

Sponsors

Molecular NeuroImaging, Invicro

Conditions

Alzheimer DiseaseHealthy VolunteersProgressive Supranuclear Palsy

Early Phase 1

Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain

CompletedNCT03058965

Molecular NeuroImagingAlzheimer Disease, Healthy Volunteers, Progressive Supranuclear Palsy

Start: 2016-11-29End: 2018-05-11Updated: 2019-03-25

Phase 1

Assessment of the Biodistribution and Safety of [18F]MNI-958 in Healthy Subjects

CompletedNCT03472313

InvicroHealthy Volunteers

Start: 2017-11-14End: 2018-04-20Updated: 2018-10-22

Phase 1 Test-retest Evaluation of [18F]MNI-958 PET

CompletedNCT03545789

InvicroAlzheimer Disease, Healthy Volunteers, Progressive Supranuclear Palsy

Start: 2018-03-12End: 2020-02-06Updated: 2020-02-17